Unknown

Dataset Information

0

CCL2 Serum Levels and Adiposity Are Associated with the Polymorphic Phenotypes -2518A on CCL2 and 64ILE on CCR2 in a Mexican Population with Insulin Resistance.


ABSTRACT: Genetic susceptibility has been described in insulin resistance (IR). Chemokine (C-C motif) ligand-2 (CCL2) is overexpressed in white adipose tissue and is the ligand of C-C motif receptor-2 (CCR2). The CCL2 G-2518A polymorphism is known to regulate gene expression, whereas the physiological effects of the CCR2Val64Ile polymorphism are unknown. The aim of the study is to investigate the relationship between these polymorphisms with soluble CCL2 levels (sCCL2), metabolic markers, and adiposity. In a cross-sectional study we included 380 Mexican-Mestizo individuals, classified with IR according to Stern criteria. Polymorphism was identified using PCR-RFLP/sequence-specific primers. Anthropometrics and metabolic markers were measured by routine methods and adipokines and sCCL2 by ELISA. The CCL2 polymorphism was associated with IR (polymorphic A+ phenotype frequencies were 70.9%, 82.6%, in individuals with and without IR, resp.). Phenotype carriers CCL2 (A+) displayed lower body mass and fat indexes, insulin and HOMA-IR, and higher adiponectin levels. Individuals with IR presented higher sCCL2 compared to individuals without IR and was associated with CCR2 (Ile+) phenotype. The double-polymorphic phenotype carriers (A+/Ile+) exhibited higher sCCL2 than double-wild-type phenotype carriers (A-/Ile-). The present findings suggest that sCCL2 production possibly will be associated with the adiposity and polymorphic phenotypes of CCL2 and CCR2, in Mexican-Mestizos with IR.

SUBMITTER: Guzman-Ornelas MO 

PROVIDER: S-EPMC4709622 | BioStudies | 2016-01-01T00:00:00Z

SECONDARY ACCESSION(S): 181450

REPOSITORIES: biostudies

Similar Datasets

2016-01-01 | S-EPMC5098736 | BioStudies
2016-01-01 | S-EPMC5053756 | BioStudies
2012-01-01 | S-EPMC3335860 | BioStudies
2015-01-01 | S-EPMC4336839 | BioStudies
1000-01-01 | S-EPMC5477505 | BioStudies
2019-01-01 | S-EPMC6689067 | BioStudies
2017-01-01 | S-EPMC5834918 | BioStudies
2012-01-01 | S-EPMC3325358 | BioStudies
2019-01-01 | S-EPMC6679398 | BioStudies
2019-01-01 | S-EPMC6465613 | BioStudies